280 pharmacies have a good harvest

As of the end of September, Yifeng Pharmacy has acquired 280 pharmacies, with a total of 7,246 stores and a total revenue of 10.

Net addition of 1255 stores

On October 29, Yifeng Pharmacy released its third quarter report

According to reported data, Yifeng added 358 stores in the third quarter, including 318 newly opened stores (including 78 newly opened franchise stores), 66 stores were acquired and 26 stores closed

In the first nine months of 2021, Yifeng opened 1051 new stores (including 242 new franchise stores), acquired 280 stores, and closed 76 stores.

As of the end of the reporting period, including 877 franchise stores, Yifeng Pharmacy has a total of 7,246 stores, with an operating area of ​​743,000 square meters of directly-operated stores

Among the 6,369 directly-operated chain stores, there are 5218 pharmacies (including 714 designated stores for special chronic disease integrated medical insurance) that have obtained the qualifications of various "medical insurance designated retail pharmacies", accounting for 81.

7 mergers and acquisitions involving 133 stores

In the third quarter, Yifeng had a total of 7 mergers and acquisitions in the same industry, including 4 completed M&A delivery projects and 3 projects in progress; 133 stores were involved, of which 66 completed delivery stores

(1) In May 2021, Hubei Yifeng, a wholly-owned subsidiary of the company, and Tang Wanyu, Tang Wanxin, and Duan Bin signed a framework agreement for the reorganization and acquisition of 12 pharmacies including Yidu Guangyuan Pharmacy, Yidu Lucheng Guangyuan Clinic, and Yidu Yipintang Clinic 》, the acquisition of 70% of the shares of the new company established by its reorganization, the transfer price of the shares was 12.

(2) In May 2021, the company signed an asset acquisition framework agreement to transfer the relevant assets and businesses of 18 pharmacies including Miluo Tianheng Jirentang Pharmacy.

(3) In June 2021, Jiangsu Yifeng, a wholly-owned subsidiary of the company, and Wang Chun and Dai Min signed the "Jiangsu Kaixin Pharmaceutical Chain Co.

(4) In September 2021, the company’s wholly-owned subsidiary Jiangsu Yifeng and Suzhou Next Station Medical Information Consulting Service Co.

(5) In September 2021, Hubei Yifeng, a wholly-owned subsidiary of the company, signed an asset acquisition framework agreement to transfer the relevant assets and businesses of 16 pharmacies belonging to Hubei Alkang Pharmacy Chain Co.

(6) In September 2021, Hubei Yifeng, a wholly-owned subsidiary of the company, and Hong Taiping signed the "Anlu Ping An Pharmacy Pharmaceutical Chain Co.

(7) In October 2021, the company signed an asset acquisition framework agreement to transfer the relevant assets and businesses of 12 pharmacies affiliated to Hunan Dehai Pharmacy Pharmaceutical and Food Retail Chain Co.

Significant increase in non-pharmaceutical gross profit

The report shows that Yifeng Pharmacy’s operating income this year reached 10.

In terms of regions, the total revenues of Central South and East China are similar, at 4.

In terms of products, in the first three quarters, the operating income of Yifeng Chinese and Western patent medicines totaled 7.
807 billion yuan, with a gross profit margin of 35.
44%; the operating income of traditional Chinese medicines totaled 990 million yuan, with a gross profit margin of 48.
36%
.

Compared with the same period of the previous year, the growth rate of the gross profit margin of pharmaceuticals was relatively stable, below 1.
5%.
Due to the sharp decline in operating costs of non-pharmaceuticals, its gross profit margin increased by 9.
06% compared with the previous year, and the gross profit margin was 50.
97%.
Non-pharmaceutical operating income in the first three quarters was 1.
753 billion yuan
.